| Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. | |
| | |
MedLine Citation:
|
PMID: 22360996 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: An increase in left ventricular mass (LVM) is associated with mortality and cardiovascular morbidity in patients with end-stage renal disease. METHODS AND RESULTS: The Frequent Hemodialysis Network (FHN) Daily Trial randomized 245 patients to 12 months of 6 times per week daily in-center hemodialysis or conventional hemodialysis; the FHN Nocturnal Trial randomized 87 patients to 12 months of 6 times per week nocturnal hemodialysis or conventional hemodialysis. The main cardiac secondary outcome was change in LVM. In each trial, we examined whether several predefined baseline demographic or clinical factors as well as change in volume removal, blood pressure, or solute clearance influenced the effect of frequent hemodialysis on LVM. In the Daily Trial, frequent hemodialysis resulted in a significant reduction in LVM (13.1 g; 95% CI, 5.0-21.3 g; P=0.002), LVM index (6.9 g/m(2); 95% CI, 2.4-11.3 g/m(2); P=0.003), and percent change in geometric mean of LVM (7.0%; 95% CI, 1.0%-12.6; P=0.02). Similar trends were noted in the Nocturnal Trial but did not reach statistical significance. In the Daily Trial, a more pronounced effect of frequent hemodialysis on LVM was evident among patients with left ventricular hypertrophy at baseline. Changes in LVM were associated with changes in blood pressure (conventional hemodialysis: R=0.28, P=0.01, daily hemodialysis: R=0.54, P<0.001) and were not significantly associated with changes in other parameters. CONCLUSIONS: Frequent in-center hemodialysis reduces LVM. The benefit of frequent hemodialysis on LVM may be mediated by salutary effects on blood pressure. Clinical Trial Registration- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00264758. |
| | |
Authors:
|
Christopher T Chan; Tom Greene; Glenn M Chertow; Alan S Kliger; John B Stokes; Gerald J Beck; John T Daugirdas; Peter Kotanko; Brett Larive; Nathan W Levin; Ravindra L Mehta; Michael Rocco; Javier Sanz; Brigitte M Schiller; Phillip C Yang; Sanjay Rajagopalan; |
Related Documents
:
|
10923306 - Effect of high amniotic fluid pressure on fetal circulation. 6776456 - Fetal acid-base state following spinal or epidural anesthesia for cesarean section. 7295836 - An improved technique for perfusion of the guinea pig placenta in situ giving viable co... 8760206 - Chemoreflex and endocrine components of cardiovascular responses to acute hypoxemia in ... 9679226 - The influence of left ventricle assist device and ventilatory support on energy-related... 8535796 - Physiological changes after delorme's procedure for full-thickness rectal prolapse. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. Date: 2012-02-23 |
Journal Detail:
|
Title: Circulation. Cardiovascular imaging Volume: 5 ISSN: 1942-0080 ISO Abbreviation: Circ Cardiovasc Imaging Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-03-22 Completed Date: 2012-05-10 Revised Date: 2013-04-15 |
Medline Journal Info:
|
Nlm Unique ID: 101479935 Medline TA: Circ Cardiovasc Imaging Country: United States |
Other Details:
|
Languages: eng Pagination: 251-61 Citation Subset: IM |
Affiliation:
|
University Health Network, Ontario, Canada. christopher.chan@uhn.ca |
| Data Bank Information | |
Bank Name/Acc. No.:
|
ClinicalTrials.gov/NCT00264758 |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Blood Pressure Canada Female Humans Hypertrophy, Left Ventricular / diagnosis, etiology*, mortality, physiopathology Kidney Failure, Chronic / complications, mortality, physiopathology, therapy* Linear Models Magnetic Resonance Imaging Male Middle Aged Proportional Hazards Models Prospective Studies Renal Dialysis / adverse effects, methods*, mortality Risk Assessment Risk Factors Time Factors Treatment Outcome United States |
| Grant Support | |
ID/Acronym/Agency:
|
R01 DK091288-01/DK/NIDDK NIH HHS; R01 DK091288-02/DK/NIDDK NIH HHS |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Inhibition of corneal inflammation following keratoplasty by birch leaf extract.
Next Document: Identification of mealybug pest species (Hemiptera: Pseudococcidae) in Egypt and France, using a DNA...